Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene
- PMID: 11601909
- DOI: 10.1006/viro.2001.1100
Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene
Abstract
Hepatitis C virus (HCV) has a propensity to cause chronic infection, with a low proportion of patients exhibiting a sustained response to interferon-alpha (IFNalpha) therapy. An earlier report suggested that HCV inhibits IFNalpha-induced signal transduction through the Jak/Stat pathway by preventing the formation of the transacting factor ISGF3 complex, although the effect on downstream pathway and the specific viral protein responsible for inhibition of IFNalpha-mediated signal transduction were not elucidated. HCV core protein displays a number of intriguing functional properties and has been implicated in virus-mediated pathogenesis. In this study, we have analyzed the effect of core protein upon IFNalpha- or IFNgamma-induced regulation of the Jak/Stat signaling pathway. HCV core protein expression exhibited a reduced Stat1 expression in IFN-treated mammalian cells. A gel retardation assay suggested a reduced level of formation of the transacting factors, GAF and ISGF3, in IFN-treated cells. Further studies from protein expression and RNase protection assay revealed that the reduced level of GAF or ISGF3 formation could be attributed to modulation of Stat1 protein expression, an important player for innate immunity in host defense mechanism. However, these modulatory effects did not interfere with the activation of the downstream effector genes, IRF-1 and 561, in IFN-treated cells. Stable transfectants of cells after introduction of a plasmid DNA encoding both the structural and the nonstructural proteins of HCV also exhibited a similar effect. Taken together, these results suggest that although expression of the core protein alone or with other HCV proteins modulate transacting factors of Jak/Stat signaling pathway, expression of the downstream effector genes IRF-1 and 561 remains unaffected upon IFN treatment and may contribute to host defense mechanism.
Copyright 2001 Academic Press.
Similar articles
-
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.J Immunol. 1999 Jan 1;162(1):323-30. J Immunol. 1999. PMID: 9886402
-
Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs.J Med Virol. 2004 Aug;73(4):536-47. doi: 10.1002/jmv.20123. J Med Virol. 2004. PMID: 15221897
-
Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.Invest Ophthalmol Vis Sci. 1999 Apr;40(5):976-82. Invest Ophthalmol Vis Sci. 1999. PMID: 10102295
-
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.Science. 1994 Jun 3;264(5164):1415-21. doi: 10.1126/science.8197455. Science. 1994. PMID: 8197455 Review.
-
Complex roles of Stat1 in regulating gene expression.Oncogene. 2000 May 15;19(21):2619-27. doi: 10.1038/sj.onc.1203525. Oncogene. 2000. PMID: 10851061 Review.
Cited by
-
Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance.J Virol. 2008 Mar;82(6):2606-12. doi: 10.1128/JVI.01672-07. Epub 2007 Dec 26. J Virol. 2008. PMID: 18160431 Free PMC article.
-
Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.PLoS One. 2011;6(12):e28617. doi: 10.1371/journal.pone.0028617. Epub 2011 Dec 12. PLoS One. 2011. PMID: 22174846 Free PMC article.
-
Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient.Clin J Gastroenterol. 2013 Apr;6(2):160-3. doi: 10.1007/s12328-013-0366-1. Epub 2013 Feb 17. Clin J Gastroenterol. 2013. PMID: 26181455
-
Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain.J Virol. 2006 Sep;80(18):9226-35. doi: 10.1128/JVI.00459-06. J Virol. 2006. PMID: 16940534 Free PMC article.
-
Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.PLoS One. 2014 Jul 7;9(7):e101993. doi: 10.1371/journal.pone.0101993. eCollection 2014. PLoS One. 2014. PMID: 24999657 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous